Last week, the Food and Drug Administration (FDA) responded to calls from our community to reconsider its role in regulating gene editing technology in animal agriculture. Despite the Trump administration’s recent directive to streamline costly and overly burdensome regulations that inhibit innovation and investment, FDA maintains it is unwilling to cede any regulatory control of this important technology.

President Donald Trump and his top trade negotiator head to the Group of 20 summit in hopes of re-starting negotiations with China before the trade war escalates further while simultaneously making progress in talks with the Japanese on reducing their barriers to U.S. farm exports.

House Democratic leaders look to finally push through on Monday a $19.1 billion disaster relief bill that a handful of conservative Republicans blocked from passing while most lawmakers were out of town for the 10-day Memorial Day recess.

The Food and Drug Administration is supporting the food industry’s use of a “best if used by” label to reduce consumer confusion leading to food waste.